When we look at how much money they make before expenses, they keep 0.084% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.755%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -2.808%. This tells us they're good at keeping money after all costs.
Return on Investments
HTG Molecular Diagnostics, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -6.646%.
Stock Prices
HTG Molecular Diagnostics, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.0025, while its low point bottomed out at $0.0015. This variance in figures offers investors a lucid insight into the roller-coaster ride that is HTG Molecular Diagnostics, Inc.'s stock market.
Profitability Ratios
HTGMQ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -280.58% underscores its earnings before tax deductions.
The effective tax rate stands at -0.06%, revealing its tax efficiency.
The net income per EBT, 100.06%, and the EBT per EBIT, 101.86%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -275.45%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-280.58%
Effective Tax Rate
-0.06%
Net Income per EBT
100.06%
EBT per EBIT
101.86%
EBIT per Revenue
-275.45%
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -2.88, and free cash flow per share, -2.89, depict cash generation on a per-share basis.
Lastly, the operating cash flow sales ratio, -1.84, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-2.88
Free Cash Flow per Share
-2.89
Operating Cash Flow Sales Ratio
-1.84
Free Cash Flow to Operating Cash Flow Ratio
1.00
Capital Expenditure Coverage Ratio
-1023.69
Dividend Paid and Capex Coverage Ratio
-1023.69
Debt and Leverage Ratios
An interest coverage of -31.17 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Interest Coverage
-31.17
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 7.16, provides a glimpse into top-line earnings distributed across each share.
Net income per share, -24.28, reflects the portion of profit attributed to each share.
The book value per share, 6.06, represents the net asset value distributed per share, while the tangible book value per share, 6.06, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
7.16
Net Income Per Share
-24.28
Book Value Per Share
6.06
Tangible Book Value Per Share
6.06
Shareholders Equity Per Share
6.06
Interest Debt Per Share
6.40
Capex Per Share
-0.03
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -28.52%, indicates top-line expansion, while the gross profit growth, -62.72%, reveals profitability trends.
EBIT growth, -16.86%, and operating income growth, -16.86%, offer insights into operational profitability progression.
The net income growth, -25.95%, showcases bottom-line expansion, and the EPS growth, 18.14%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-28.52%
Gross Profit Growth
-62.72%
EBIT Growth
-16.86%
Operating Income Growth
-16.86%
Net Income Growth
-25.95%
EPS Growth
18.14%
EPS Diluted Growth
18.14%
Weighted Average Shares Growth
53.85%
Weighted Average Shares Diluted Growth
53.85%
Operating Cash Flow Growth
-11.50%
Free Cash Flow Growth
-7.45%
10-Year Revenue Growth per Share
-99.47%
5-Year Revenue Growth per Share
-97.14%
3-Year Revenue Growth per Share
-92.11%
10-Year Operating CF Growth per Share
99.56%
5-Year Operating CF Growth per Share
92.65%
3-Year Operating CF Growth per Share
73.76%
10-Year Net Income Growth per Share
99.65%
5-Year Net Income Growth per Share
92.46%
3-Year Net Income Growth per Share
73.37%
10-Year Shareholders Equity Growth per Share
100.06%
5-Year Shareholders Equity Growth per Share
111.67%
3-Year Shareholders Equity Growth per Share
-94.65%
Receivables Growth
-32.06%
Inventory Growth
-54.25%
Asset Growth
-41.64%
Book Value per Share Growth
-66.30%
Debt Growth
-58.72%
R&D Expense Growth
11.38%
SGA Expenses Growth
-4.26%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -3,828,665.84, captures the company's total value, considering both debt and equity.
Income quality, 0.85, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
-3,828,665.84
Income Quality
0.85
Research and Development to Revenue
106.53%
Capex to Operating Cash Flow
0.13%
Capex to Revenue
-0.36%
Capex to Depreciation
-3.92%
Stock-Based Compensation to Revenue
12.79%
Graham Number
57.56
Return on Tangible Assets
-121.47%
Graham Net Net
1.51
Working Capital
7,380,694
Tangible Asset Value
5,391,697
Net Current Asset Value
3,265,493
Invested Capital
1
Average Receivables
1,757,080.5
Average Payables
1,403,444.5
Average Inventory
1,448,540.5
Days Sales Outstanding
82
Days Payables Outstanding
92
Days of Inventory On Hand
73
ROIC
-203.80%
ROE
-4.01%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
